The ankle-brachial index is a ratio comparing blood pressure at your ankle to blood pressure in your arm, and it serves as a quick, noninvasive gauge of how well blood is flowing to your lower limbs. A normal value falls roughly between 1.00 and 1.40, while anything at or below 0.90 is widely used to diagnose peripheral artery disease. The test takes about ten to fifteen minutes, requires only a blood pressure cuff and a Doppler probe, and yet the number it produces carries implications well beyond the legs.
How the Test Is Performed
The setup matters more than people expect. You lie flat on your back for at least five to ten minutes before anyone takes a reading. That rest period lets blood pressure settle to a baseline; skipping it or shortening it introduces error that can push your result in either direction. Recent smoking, caffeine intake, and physical activity also throw off resting pressures, so ideally you avoid all three before the test.
A clinician wraps a standard blood pressure cuff around your upper arm and inflates it while listening with a handheld continuous-wave Doppler probe placed over the brachial artery. They record the systolic pressure at which the Doppler signal returns as the cuff deflates. The same process is repeated on the other arm. Then the cuff moves to just above each ankle, and the clinician records systolic pressure over the posterior tibial artery (the one behind the inner ankle bone) and the dorsalis pedis artery (on top of the foot). In standard practice, the higher of the two ankle pressures on each side is divided by the higher of the two arm pressures. That ratio is your ABI for that leg.
Several pre-test variables can shift the result. Body position, the length of the rest period, and even the ambient temperature all affect vascular tone and therefore the measurement. A systematic review examining ABI reliability found that variations in body position, recency of tobacco use, caffeine intake, and exercise all introduce enough error to affect test-retest consistency.
Reading the Numbers
The interpretation is straightforward in most people. An ABI between about 1.00 and 1.40 is considered normal. Values between 0.91 and 0.99 sit in a borderline zone that warrants attention. An ABI at or below 0.90 is the standard threshold for diagnosing peripheral artery disease, with lower numbers reflecting more severe obstruction. Values above 1.40 are flagged as abnormally high, which usually means the arteries in the legs are too stiff to compress normally rather than that blood flow is actually excellent.
Research from the Multi-Ethnic Study of Atherosclerosis has suggested the “normal” floor may actually be higher than 1.00 for some people. In that study, men with an ABI below 1.10 and women below 1.00 already showed excess atherosclerosis in the coronary and carotid arteries compared with those at higher ABI values.1American Journal of Epidemiology. Ankle-Brachial Index and Subclinical Cardiac and Carotid Disease: The Multi-Ethnic Study of Atherosclerosis That finding matters because someone with an ABI of, say, 0.95 might be told they are fine when they are actually in a higher-risk group.
What a Low ABI Tells You About the Rest of Your Body
A low ABI does not just flag a circulation problem in the legs. It acts as a window into the health of arteries everywhere. The underlying logic is simple: atherosclerosis is a systemic disease. If plaque is narrowing the arteries feeding your calves and feet, it is often building up in coronary, carotid, and cerebral arteries too.
A large meta-analysis pooling data from over 44,000 people across six countries found that an ABI below 0.90 was linked to a roughly 60 percent higher risk of dying from any cause, nearly double the risk of cardiovascular death, and modestly elevated risks of coronary heart disease and stroke, even after adjusting for conventional risk factors like smoking, cholesterol, and blood pressure.2Atherosclerosis. Prognostic value of the ankle-brachial index and chronic kidney disease on mortality A separate meta-analysis published in JAMA found the relationship was even steeper when the ABI was combined with standard risk scoring: a low ABI roughly doubled the ten-year rate of total mortality, cardiovascular mortality, and major coronary events within each existing risk category.3PubMed Central. Ankle Brachial Index Combined with Framingham Risk Score to Predict Cardiovascular Events and Mortality: A Meta-analysis
The connection extends to specific vascular beds. A study of patients undergoing coronary angiography found that ABI was independently and inversely related to the thickness of the carotid and femoral artery walls, and it correlated with the number of diseased coronary arteries.4American Journal of Cardiology. Relation of Ankle-Brachial Index to Severity of Coronary Atherosclerosis and Extracoronary Involvement in Patients Undergoing Coronary Angiography In women specifically, a low ABI has been linked to moderate-to-severe carotid artery narrowing, though interestingly, the same study did not find a statistically significant relationship between ABI and cardiac disease in that population.5PubMed. Correlation of ankle-brachial index values with carotid disease, coronary disease, and cardiovascular risk factors in women That discrepancy is a reminder that ABI is better at catching widespread arterial disease than at predicting the precise location of the next event.
Where the Test Becomes Unreliable
ABI’s biggest weakness is its sensitivity, meaning how well it catches disease that actually exists. The test has excellent specificity: if it says you have peripheral artery disease, you almost certainly do. But a normal reading does not guarantee your arteries are clear, and this gap widens dramatically in certain populations.
In people with diabetes, the arteries in the lower legs often develop medial calcification, a process where calcium deposits stiffen the vessel wall. These rigid arteries resist compression from the blood pressure cuff, artificially inflating the ankle pressure and producing a falsely reassuring ABI. One study of people with diabetes in a community screening setting found that ABI had a specificity of about 98 percent but a sensitivity of only about 35 percent.6PubMed Central. Accuracy of ankle-brachial index in screening for peripheral arterial disease in people with diabetes In practical terms, roughly two out of three people with diabetes who actually had peripheral artery disease were missed by the ABI.
Chronic kidney disease compounds the problem. A study analyzing ABI performance against angiographic evidence of at least 50 percent arterial narrowing found that sensitivity dropped to about 43 percent in people with chronic kidney disease, compared with 60 percent in those without it. For people with diabetes, sensitivity was about 51 percent versus 66 percent in nondiabetics.7PubMed Central. Critical analysis and limitations of resting ankle-brachial index in the diagnosis of symptomatic peripheral arterial disease patients and the role of diabetes mellitus and chronic kidney disease When diabetes and kidney disease overlap in the same patient, the ABI becomes especially unreliable.
The abnormally high ABI, above 1.40, is itself a clinical finding rather than just noise. An elevated ABI in people at risk for vascular disease is thought to reflect poorly compressible vessels characterized by medial arterial calcification, a process associated with reduced arterial compliance and organ damage.8PubMed Central. Arterial Compliance Across the Spectrum of Ankle-Brachial Index: The Multiethnic Study of Atherosclerosis So an ABI above 1.40 should not be read as “great circulation” but rather as “the test cannot work properly in these arteries, and that stiffness is itself a bad sign.”
What to Do When ABI Is Not Enough
When ABI is unreliable or when symptoms suggest disease despite a normal resting value, clinicians have two main alternatives: the toe-brachial index and exercise testing.
The Toe-Brachial Index
The toe-brachial index works on the same principle as the ABI but measures pressure in the big toe instead of at the ankle. The key advantage is that the small digital arteries in the toes are largely spared from the medial calcification that plagues the tibial arteries. A value below 0.70 generally indicates peripheral artery disease.
A study comparing both tests in people with type 2 diabetes found that the toe-brachial index detected disease confirmed by CT angiography with a sensitivity of about 82 percent, compared with just 35 percent for the ABI. The two tests had similar specificity.9PubMed Central. Toe brachial index and not ankle brachial index is appropriate in initial evaluation of peripheral arterial disease in type 2 diabetes The researchers argued that the toe-brachial index should be the first-line test in people with type 2 diabetes rather than the ABI. That is a stronger claim than most current guidelines endorse, but the sensitivity gap is hard to ignore.
Exercise Testing
Some people have leg pain with walking that suggests claudication, yet their resting ABI is normal. A treadmill exercise test can unmask disease that only shows up when the muscles demand more blood. The patient walks on a treadmill at a standardized pace and grade, and ankle pressures are measured immediately afterward. A significant drop in post-exercise ankle pressure, even from a normal baseline, points to atherosclerotic narrowing that resting blood flow was able to compensate for.10Journal for Vascular Ultrasound. Exercise Stress Testing Is a Useful Adjunct in the Evaluation of Patients With Claudication and Normal Ankle-Brachial Index When exercise testing is not feasible, the toe-brachial index offers another way to detect disease behind a normal resting ABI.11PubMed. The Ability of the Toe-Brachial Index to Predict the Outcome of Treadmill Exercise Testing in Patients with a Normal Resting Ankle-Brachial Index
Automated Devices Versus Handheld Doppler
The traditional ABI measurement requires a trained operator to hold a Doppler probe at the right angle, find the artery, and listen for the signal while slowly deflating a cuff. This skill dependency is one reason the test is underused in busy primary care clinics. Automated oscillometric devices, which work like the digital blood pressure monitors many people have at home, promise a simpler alternative that any office staff member could use without special training.
The agreement between automated and manual methods is reasonable but not perfect. A validation study found that the difference between the two approaches was small on average, roughly 0.03 units or less, depending on which ankle artery was used for the manual measurement. However, the discrepancy was not uniform across the ABI range: at lower ABI values the automated device tended to read higher than the Doppler, while at values above about 1.1 the Doppler read higher.12Hypertension Research. Validation of automated oscillometric versus manual measurement of the ankle–brachial index That pattern is clinically relevant because it means automated devices may slightly overestimate ABI in the people who matter most, those near the diagnostic threshold.
A study in patients with type 2 diabetes found that the automated method had about 60 percent sensitivity and over 93 percent specificity compared with handheld Doppler, and the researchers concluded it was a reasonable substitute in settings where trained Doppler operators are unavailable.13PubMed Central. Comparison of ankle-brachial index (ABI) measured by an automated oscillometric apparatus with that by standard hand-held doppler in patients with Type-2 diabetes The takeaway is practical: an automated ABI is better than no ABI, but if the result is borderline or if there is a strong clinical suspicion of disease, a Doppler-based measurement should follow.
Who Should Be Tested
Not everyone needs an ABI. Screening guidelines try to balance the test’s simplicity and low cost against the limited benefit of finding asymptomatic disease in people at low risk. The American College of Cardiology and the American Heart Association recommend ABI screening for adults 65 and older, adults 50 and older who have risk factors for atherosclerosis or a family history of peripheral artery disease, and adults under 50 who have diabetes plus at least one other atherosclerotic risk factor. The Society for Vascular Surgery takes a slightly different approach, recommending against screening in the absence of risk factors but considering it reasonable in adults over 70, current smokers, people with diabetes, those with an abnormal pulse exam, or those with established cardiovascular disease elsewhere.14Journal of the American Medical Association. Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index
If you have leg symptoms that suggest poor circulation, cramping with walking that resolves with rest, wounds on the feet that heal slowly, or legs that feel cool or look pale, ABI testing is indicated regardless of your age or risk profile. In those cases the test is diagnostic, not screening, and the threshold for ordering it is lower.
ABI After a Bypass or Procedure
ABI is sometimes repeated after a leg bypass or stent placement to monitor whether the repair is holding up. The logic seems sound: if the graft is open and flowing, the ABI should improve. But the evidence here is mixed. A study of patients who underwent lower-extremity bypass found that skipping the perioperative ABI was associated with higher rates of graft patency loss, yet the ABI did not add much predictive value beyond simply tracking whether the patient’s symptoms improved.15PubMed. The Impact of Perioperative Ankle-Brachial Index and Clinical Status on Outcomes following Lower Extremity Bypass In practice, many vascular surgeons use a combination of ABI, duplex ultrasound, and clinical assessment to follow grafts rather than relying on any one measure alone.
Is Screening Cost-Effective
The economics of ABI screening depend heavily on who you are screening. A cost-effectiveness model examining one-time ABI screening in asymptomatic adults estimated an incremental cost-effectiveness ratio of about $89,000 per quality-adjusted life-year, which hovers around commonly used willingness-to-pay thresholds in the United States. However, when the model focused on higher-risk groups like current smokers, where peripheral artery disease is roughly two and a half times more common, the ratio dropped to about $24,000 per quality-adjusted life-year, a figure most health economists would call favorable.16PubMed Central. Cost Effectiveness Analysis of Asymptomatic Peripheral Arterial Disease Screening with the ABI Test
The picture changes when you look at screening people who already have coronary artery disease. A separate analysis of ABI screening in that group found an incremental cost-effectiveness ratio of over $207,000 per quality-adjusted life-year, driven largely by the high cost of adding rivaroxaban to treatment regimens after a positive screen. Only if the drug cost dropped below about $95 per month did screening become cost-effective in that population.17PubMed. Cost-effectiveness analysis of ankle-brachial index screening in patients with coronary artery disease to optimize medical management The broader point is that the value of finding asymptomatic peripheral artery disease hinges on what you do with the information and how much that treatment costs. Screening is only as useful as the intervention that follows it.
The Hemodynamics Behind the Disease
Peripheral artery disease is fundamentally a disease of disturbed blood flow. As plaque builds in a leg artery, it does not just narrow the channel; it changes how blood moves along the vessel wall. A study using advanced ultrasound flow mapping found that patients with peripheral artery disease had globally lower wall shear stress and higher oscillatory shear compared with healthy controls, even in segments of the artery that appeared plaque-free.18Journal of the American Heart Association. Wall-Specific V-Flow Hemodynamics in Lower-Limb Peripheral Artery Disease: Diagnostic Nomogram and Periplaque Mapping Low and oscillating shear stress is known to promote further plaque growth and inflammation, which helps explain why peripheral artery disease tends to progress: the flow disturbance from one plaque makes conditions favorable for the next one to form nearby. It also underscores why catching the disease early, when ABI first dips below normal, matters more than waiting for symptoms to appear.